In vitiligo, a chronic hypomelanotic disorder, an increased presence of MMP9 is implicated with loss of melanocytes and associated hypopigmentation, via decreased expression of E-cadherin at the peri-lesional sites [69]. Here, CDH1 is linked to vitiligo.